Floatz logo

Dimethyl Sulfoxide

Radiation Dermatitis

Dennis Bregner ZetnerSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Radiation Dermatitis cohort.

Asset / SponsorPhaseRating
Olea europaea oil
Cairo University
Phase 4BB
BETAMETHASONE
Cairo University
Phase 4BB
Urea
University of Brasilia
Phase 3BB
Mometasone
North Central Cancer Treatment Group
Phase 3BB
Chamomilla recutita
University of Brasilia
Phase 3BB

View all 33 →

Same molecule, other indications

Dimethyl Sulfoxide is also rated in:

TinnitusDormant
CCC
Indicative ·
53 / 100
View asset →
breast cancerDormant
CCC
Indicative ·
48 / 100
View asset →
cutaneous melanomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →